ScholarIQanswers from OpenAlex
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
PaperCitations, authors & open-access status
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC have?
ScholarIQcitation count
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC has 418 citations in the OpenAlex counts ScholarIQ stores.
When was Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC published?
ScholarIQyear
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC has 2020 year in the ScholarIQ index.
What is the open-access status of Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC?
ScholarIQoa status
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC has hybrid oa status in the ScholarIQ index.
What is the DOI of Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC?
ScholarIQdoi
The DOI for Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC is on the source record.
What is the PMID of Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC?
ScholarIQpmid
The PMID for Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC is on the source record.
What is the OpenAlex record for Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC?
ScholarIQopenalex
The OpenAlex for Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC is on the source record.